Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
September-2017 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
September-2017 Volume 16 Issue 3

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition

  • Authors:
    • Sisi Weng
    • Lei Mao
    • Yuanyuan Gong
    • Tao Sun
    • Qing Gu
  • View Affiliations / Copyright

    Affiliations: Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Hongkou, Shanghai 200080, P.R. China
  • Pages: 3461-3468
    |
    Published online on: July 13, 2017
       https://doi.org/10.3892/mmr.2017.6964
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Age‑related macular degeneration (AMD) is a common cause of irreversible blindness in the elderly in the western world. Research has demonstrated that degenerative and progressive conditions of retinal pigmented epithelial (RPE) cells are the key pathogenic mechanisms in AMD. Previous research has indicated the anti‑apoptosis, anti‑oxidant, anti‑inflammatory and anti‑cancer properties of quercetin. Therefore, the present study aimed to investigate the protective effects of quercetin on the ARPE‑19 human retinal pigment epithelial cell line. ARPE‑19 cells were pretreated with various concentrations of quercetin (0‑80 µM) before exposure to 300 µM H2O2. Cell viability was assessed and reactive oxygen species (ROS) were determined. The importance of the NF‑E2‑related factor 2 (Nrf2) signaling pathway was corroborated by western blotting and immunostaining. The protein expression levels of endoplasmic reticulum‑associated stress responsive genes and apoptotic markers were assessed by western blotting. The results demonstrated that in the H2O2 group, cell viability was weakened, but preserved in quercetin group in a dose‑dependent manner, particularly at 20 µM. The level of ROS decreased in the quercetin group compared with the control groups. In the quercetin group, the expression levels of Nrf2 and phase II enzymes (NQO1 and HO‑1) were increased, whereas the levels of ER stress markers (binding of immunoglobulin protein, CCAAT/enhancer‑binding protein homologous protein and phosphorylated eukaryotic translation initiation factor 2α) were reduced. Cell apoptosis‑associated protein expression levels were altered, with the increase of B‑cell lymphoma 2 and reduction of Bcl‑2 X‑associated protein. In conclusion, quercetin protected ARPE‑19 cells from H2O2‑induced cytotoxicity by activating the Nrf2 pathway, inhibiting ER stress and targeting anti‑apoptotic proteins.

Introduction

Age-related macular degeneration (AMD) is a common cause of irreversible blindness in the elderly in the western world. It is estimated that 1.47% of the US population (>40 years) are suffering from AMD, and the likelihood of AMD is expected to increase by 50% (to 2.95 million) by 2020 (1). Although the pathogenic mechanism underlying the progression of AMD is currently unknown, research has demonstrated that degenerative and progressive conditions of retinal pigmented epithelial (RPE) cells are the key pathogenic mechanisms in AMD (2).

RPE cells serve a critical role in protecting the outer retina from photo-oxidative stress, maintaining the viability of photoreceptors and inhibiting retinal edema and neovascularization (3). Oxidative stress is considered to be particularly vital in the development of RPE cell degeneration, dysfunction and apoptosis (4).

NF-E2-related factor 2 (Nrf2) has been demonstrated to regulate the expression of genes encoding detoxification enzymes, antioxidant proteins and other stress-response mediators, including heme oxygenase-1 (HO-1) and NAD(P)H, quinone oxidoreductase 1 (NQO1) (5). In vivo and in vitro studies have highlighted the central role of Nrf2 in protecting RPE cells from a variety of oxidative challenges. Previous studies have demonstrated that antioxidants could mitigate oxidative stress in RPE cells by upregulating Nrf2-regulated phase II enzymes (6,7). A study demonstrated that RPE cells of aged mice expressed higher levels of the Nrf2 target genes compared with RPE of younger mice, especially under unstressed conditions, thereby indicating an age-associated increase in basal oxidative stress (8). RPE cells of older mice exhibited impaired induction of the Nrf2 signaling pathway following oxidative stress, thereby suggesting that the aged RPE cells are vulnerable to oxidative damage due to impaired Nrf2 signaling (8). The Nrf2 pathway may serve an important role in AMD pathogenesis and function as a promising target for novel pharmacologic or genetic therapeutic strategies.

Endoplasmic reticulum (ER) stress is considered to be an early or initial response of cells to stress or damage. Disturbed ER homeostasis could induce the unfolded protein response (UPR) accumulation, thereby triggering cell death responses (9). Growing evidence has suggested that ER stress serves an important role in retinal diseases. Libby and Gould (10) proposed that ER stress could be an important mechanism in the pathogenesis of AMD. A previous study demonstrated that exposure of A2E containing ARPE-19 cells to blue light resulted in significant apoptosis and increased levels of ER stress markers, indicating that photo-oxidative damage to RPE cells was mediated by the ER stress-induced intrinsic apoptotic pathway (11). Therefore, therapeutic agents that inhibit ER stress may protect RPE from dysfunction and apoptosis during the course of development of AMD.

Quercetin is a ubiquitous flavonoid compound, which is widely distributed in different fruits and vegetables, including onions, capers, cranberries, fennel, dark grapes and cocoa. Experimental data has suggested that quercetin serves as a strong free radical scavenger and possesses anti-apoptosis, anti-oxidant, anti-inflammatory and anti-cancer properties (12,13). Although a previous study demonstrated that precubation with quercetin could protect RPE cells from H2O2-induced oxidative damage and attenuate cellular senescence increase in vitro in a dose-dependent manner (14), the underlying mechanism remains unclear. Furthermore, the association between Nrf2 and quercetin remains to be investigated. The role of quercetin in promoting the expression of Nrf2 and downstream signaling molecules and modulating ER stress and apoptosis proteins remains unclear. To confirm this, the present cultured ARPE-19 cells with quercetin prior to H2O2 stimulation and investigated the underlying molecular mechanism.

Materials and methods

Materials

The human retinal pigment epithelial cell line ARPE-19 was obtained from the American Type Culture Collection (Manassas, VA, USA). Dulbecco's modified Eagle's medium/nutrient mixture F12 (DMEM/F12) trypsin-EDTA was obtained from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). Quercetin, 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA), dimethyl sulfoxide (DMSO) and H2O2 were purchased from Sigma-Aldrich; Merck KGaA (Darmstadt, Germany). A CellTiter 96® AQueous One Solution Cell Proliferation Assay kit (MTS) was obtained from Promega Corporation (Madison, WI, USA). The NE-PER™ Nuclear and Cytoplasmic Extraction reagent was obtained from Thermo Fisher Scientific, Inc. The antibodies for Nrf2 (cat. no. ab31163), NQO1 (cat. no. ab80588), HO-1 (cat. no. ab68477) and Laminin B1 (cat. no. ab109293) were obtained from Abcam (Cambridge, MA, USA). Antibodies for binding of immunoglobulin protein (Bip; cat. no. 3177S), CCAAT/enhancer-binding protein homologous protein (CHOP; cat. no. 5554S), phosphorylated (p) eukaryotic translation initiation factor 2α (eIF2α; cat. no. 3398), eIF2α (cat. no. 5324S), B-cell lymphoma 2 (Bcl-2; cat. no. 15071S), Bcl-2 X-associated protein (Bax; cat. no. 5023S) and β-actin (cat. no. 12620S), and Alexa Fluor 488-conjugated anti-rabbit secondary antibody (cat. no. 4412S) were purchased from Cell Signaling Technology (Beverly, MA, USA). Horseradish peroxidase (HRP)-conjugated anti-mouse (cat. no. ab6789) and anti-rabbit (cat. no. ab6721) secondary antibodies were purchased from Abcam. An enhanced chemiluminescence (ECL) kit and polyvinylidene difluoride (PVDF) membranes were obtained from EMD Millipore (Billerica, MA, USA).

In addition, quercetin was freshly dissolved in 100% DMSO and further diluted with culture medium on the day of experiment. The final concentration of DMSO in each experiment was <0.1%. H2O2 was diluted with double-distilled water to the desired concentration at the beginning of each experiment.

Cell culture

ARPE-19 cells were cultured in DMEM/F12 supplemented with 10% fetal bovine serum and 1X penicillin-streptomycin solution (Gibco; Thermo Fisher Scientific, Inc.) at 37°C in 5% CO2/95% air. For monolayer culture, ARPE-19 cells were seeded at high confluence at a density of 4×105 cells/well, and maintained for 3 days to form a monolayer. The culture medium was replaced every 48 h. The cells were passaged once a week, with a split ratio of 1:3.

Cell viability studies

Inhibition of cell proliferation by different concentrations of H2O2 or quercetin was measured using an MTS kit according to the manufacturer's protocol. Briefly, the cells were seeded into 96-well culture plates (104 cells/well) in 100 µl media, and different concentrations of H2O2 or quercetin were added. After treatment, 20 µl MTS solution was added to each well, and the cells were further incubated in 5% CO2 for 1 h. The plates were read at 450 nm using a microplate reader (Model EL800; Omega Bio-Tek, Inc., Norcross, GA, USA). All the experiments were conducted in triplicate.

Measurement of intracellular reactive oxygen species (ROS) levels

Production was determined by DCFH-DA staining assay. Briefly, following treatment, ARPE-19 cells were incubated with 10 µM DCFH-DA at 37°C for 30 min in the dark. The cells were washed twice with PBS, resuspended, and subjected to flow cytometry with a CytoFLEX flow cytometer (Beckman Coulter, Inc., Brea, CA, USA) at excitation and emission wavelengths of 488 nm and 525 nm, respectively. The results were expressed as fluorescence intensity of DCF.

Immunofluorescence microscopy

ARPE-19 cells were seeded into 24-well glass slides (Merck KGaA) at a density of 4×105 per well. After treatment, the cells were washed twice with ice-cold phosphate-buffered saline (PBS) and fixed in 4% paraformaldehyde at room temperature for 20 min. The cells were permeabilized with 0.05% Triton X-100 in PBS for 10 min. After washing with ice-cold PBS, the cells were blocked with 3% bovine serum albumin (Gibco; Thermo Fisher Scientific, Inc.) for 15 min, followed by incubation with primary antibodies against Nrf2 (1:200) overnight at 4°C. The cells were then washed three times with PBS and incubated for 1 h with an Alexa Fluor 488-conjugated secondary antibody at room temperature. 4′-6-diamidino-2-phenylindole (DAPI; 5 mg/ml; Beyotime Institute of Biotechnology, Nanjing, China) in PBS was used to stain the nuclei. Fluorescence photographs were acquired by a fluorescence microscope.

Protein extraction

Following appropriate treatment, cells were trypsinized and collected by centrifugation at 1,000 × g for 10 min at room temperature, washed briefly with PBS, resuspended in lysis buffer [50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100] and supplemented with protease and phosphatase inhibitors (Thermo Fisher Scientific, Inc.). The suspension was left on ice for 30 min and then centrifuged at 15,000 × g for 10 min at 4°C. Cytoplasmic and nuclear extracts were collected using NE-PER™ Nuclear and Cytoplasmic Extraction reagents according to the manufacturer's protocol. All the protein extracts were stored at −80°C until use. Protein concentrations were determined using a Bicinchoninic Acid Protein Assay kit (Beyotime Institute of Biotechnology).

Western blotting

Equal amounts of extracted protein samples (40 µg) were separated on Tris-HCl 10% polyacrylamide gels (Ready Gel; Bio-Rad Laboratories, Inc., Hercules, CA, USA) at 100 V and subsequently transferred onto a PVDF membrane. After blocking with 5% instant non-fat dry milk for 1 h, the membranes were incubated with the following primary antibodies at 4°C overnight: Anti-Nrf2 (1:2,000), anti-NQO1 (1:5,000), anti-HO-1 (1:5,000), anti-Bip (1:1,000), anti-Chop (1:1,000), anti-p-eIF2α (1:1,000), anti-eIF2α (1:1,000), anti-Bcl-2 (1:1,000), anti-Bax (1:1,000), anti-β-actin (1:1,000) and anti-Laminin B1 (1:2,000), followed by incubation with the following secondary antibodies for 1 h at room temperature: Alexa Fluor 488-conjugated anti-rabbit secondary antibody (1:1,000) and HRP-conjugated anti-mouse and anti-rabbit secondary antibodies (1:1,000). Protein bands were detected with an enhanced chemiluminescence (ECL) detection kit (EMD Millipore) using an ECL detection system (GE Healthcare, Chicago, IL, USA). Blots were semi-quantified by densitometry using Quantity One software version 4.62 (Bio-Rad Laboratories, Inc.).

Statistics analysis

Each experiment was repeated at least three times. Data are expressed as the mean ± standard deviation. Statistical analyses were performed using unpaired Student's t-test for two-group data and one-way analysis of variance followed by a post hoc Bonferroni's multiple comparison test for three groups or more. Statistical analysis was performed using GraphPad Prism software version 6.0 (GraphPad Software, Inc., La Jolla, CA, USA). P<0.05 was considered to indicate a statistically significant difference.

Results

Effects of H2O2 and quercetin on cell viability in ARPE-19 cells

To determine the concentration of H2O2, ARPE-19 cells were treated with 0–1,000 µM H2O2 for 24 h, and the dose-dependent cell toxicity of H2O2 was measured by MTS assay. As presented in Fig. 1A, H2O2 progressively decreased the viability of ARPE-19 cells. However, for further studies, 300 µM H2O2 was used, where the cell viability was decreased to 63.97±0.99% (P<0.05). In order to evaluate the potential toxicity quercetin towards ARPE-19 cells, the of cells were incubated with 0–80 µM quercetin for 24 h, and the cell viability was tested (Fig. 1B). Experimental data demonstrated that quercetin treatment alone had no effect on cell viability; thereby demonstrating that quercetin at the tested concentrations was safe for cultured ARPE-19 cells.

Figure 1.

Inhibitory effect of quercetin on H2O2-induced injury in ARPE-19 cells. Cells were treated with (A) H2O2, (B) quercetin and (C) or a combination of the two at various concentrations for 24 h, and cell viability was determined by CellTiter 96® AQueous One Solution Cell Proliferation assay. Data are expressed as the mean ± standard deviation. *P<0.05 vs. control, #P<0.05 vs. H2O2-induced cells without pretreatment with quercetin. QUE, quercetin.

Effect of quercetin on inhibiting H2O2-induced toxicity in ARPE-19 cells

To investigate whether quercetin treatment could protect ARPE-19 cells from H2O2-induced cell damage, the cells were first incubated in medium containing different concentrations of quercetin. After 24 h of treatment, the medium was removed and the cells were exposed to 300 µM H2O2 for another 24 h. Cell viability was determined by MTS assay. As presented in Fig. 1C, the cell viability was significantly decreased to 65.53±1.77% (P<0.05) in cultures treated with H2O2 alone as compared with untreated cells. There was no statistically significant difference in cell viability of incubation with quercetin at low concentrations of 2.5 µM (64.40±2.89%; P>0.05) and 5 µM (66.33±1.91%; P>0.05) compared with the H2O2 group; however, pretreatment of quercetin at concentrations of 10, 20, 40 and 80 µM protected up to 77.97±1.36% (P<0.05), 86.87±1.80% (P<0.05), 81.67±1.29% (P<0.05) and 76.67±2.40% (P<0.05) of ARPE-19 cells from H2O2-induced cell death, compared with 65.53±1.77% in the control group (300 µM H2O2; Fig. 1C). In this study, 20 µM quercetin was used for all the experiments.

Quercetin pretreatment reduces H2O2-induced intracellular generation of ROS

To evaluate the effect of quercetin on H2O2-induced ROS generation in ARPE-19 cells, the cells were incubated with 20 µΜ quercetin for 24 h before exposure to 300 µM H2O2 for another 24 h. It was observed that treatment of cells with 300 µM H2O2 resulted in an increase in the intracellular level of ROS. ROS accumulation was reduced following pretreatment with quercetin at concentration of 20 µM (Fig. 2).

Figure 2.

Quercetin reduces H2O2-induced intracellular generation of ROS. (A) ARPE-19 cells were pretreated with the 20 µM quercetin for 24 h, followed by 300 µM H2O2 administration. ROS production was evaluated using (A) flow cytometry (B) with quantification. Data are presented as the mean ± standard deviation. *P<0.05 vs. control, #P<0.05 vs. H2O2-induced cells without pretreatment with quercetin. QUE, quercetin; ROS, reactive oxygen species; FITC, fluorescein isothiocyanate.

Effect of quercetin on activation of Nrf2 and phase II enzymes

It has been well documented that Nrf2 and dependent genes, NQO1 and HO-1, are important components of the cellular stress response. To investigate the potential effect of quercetin on the expression of Nrf2 and NQO1, the cells were incubated with 20 µM quercetin for different time intervals (0–48 h), and the expression levels of Nrf2 and NQO1 were examined. It was observed that 20 µM quercetin administration induced protein expression of Nrf2 and NQO1 in a time-dependent manner (Fig. 3A).

Figure 3.

Effects of quercetin on activation of Nrf2 and phase II enzymes in ARPE-19 cells. (A) Western blot images and quantification of Nrf2 and NQO1 protein expression levels in cells incubated with 20 µM quercetin for 0, 6, 12, 24 and 48 h. (B) Representative immunofluorescence images of activation of Nrf2 in ARPE-19 cells. Magnification, ×400. Western blot images and quantification of (C) total and nuclear Nrf2, and (D) HO-1 and NQO1 protein expression levels in cells. Data are presented as the mean ± standard deviation. *P<0.05 vs. control, #P<0.05 vs. H2O2-induced cells without pretreatment with quercetin. QUE, quercetin; Nrf2, NF-E2-related factor 2; NQO1, NAD(P)H, quinone oxidoreductase 1; HO-1, heme oxygenase-1.

Furthermore, the location of Nrf2 was examined by immunofluorescence experiments. It was observed that H2O2 alone could only slightly enhance the Nrf2 expression in the cytoplasm; however, quercetin treatment significantly stimulated the expression and accumulation of Nrf2 and induced the nuclear translocation of Nrf2 in ARPE-19 cells (Fig. 3B). Western blotting results also revealed that quercetin supplementation enhanced the total expression levels of Nrf2 and significantly increased nuclear levels of Nrf2 in the quercetin pretreatment group, compared with H2O2 (Fig. 3C). The expression level of NQO1 was increased significantly as well. HO-1 was also increased, but no significant difference was detected (Fig. 3D).

Effect of quercetin on ER stress markers under H2O2 stimulation

To confirm the protective effect of quercetin against H2O2-induced ER stress in ARPE-19 cells, expression levels of ER stress markers were assessed by western blotting. The results demonstrated that Bip and CHOP expression levels were downregulated, with eIF2α phosphorylation reduction, following quercetin pretreatment, compared with H2O2 alone. This finding demonstrated that quercetin could inhibit ER stress in ARPE-19 cells during H2O2-induced injury (Fig. 4A-D).

Figure 4.

Effects of quercetin on endoplasmic reticulum stress markers and apoptosis-associated proteins in ARPE-19 cells. Cells were incubated with 300 µM H2O2 with or without 20 µM quercetin administration. (A) Representative western blot images and quantification of (B) Bip, (C) CHOP and (D) eIF2α and p-eIF2α protein expression levels. (E) Representative western blot images and quantification of (F) Bax, (G) Bcl-2 and (H) the ratio of Bcl-2/Bax protein expression levels. Data are presented as the mean ± standard deviation. *P<0.05 vs. control, #P<0.05 vs. H2O2-induced cells without pretreatment with quercetin. QUE, quercetin; Bip, binding of immunoglobulin protein; CHOP, CCAAT/enhancer-binding protein homologous protein; p, phosphorylated; eIF2α, eukaryotic translation initiation factor 2α; Bcl-2, B-cell lymphoma 2; Bax, Bcl-2 X associated protein.

Effect of quercetin on apoptosis-associated proteins in ARPE-19 cells

To further investigate the effect of quercetin on apoptosis-associated proteins, the expression levels of Bcl-2 and Bax were evaluated. The results demonstrated that in the quercetin-pretreated group, the expression level of Bcl-2 was upregulated, and Bax was downregulated (Fig. 4E-G). The Bcl-2/Bax ratio declined in H2O2 group, while it was significantly increased with the administration of quercetin (20 µΜ; Fig. 4H).

Discussion

Quercetin is an important dietary polyphenol, which is present in several foods. The present study assessed the cytotoxic effects of quercetin on ARPE-19 cells and observed that quercetin does not influence the viability of APRE-19 cells. The results demonstrated that a higher concentration of quercetin attenuated H2O2-induced cytotoxicity in ARPE-19 cells, particularly at 20 µΜ concentration.

ROS have been implicated in the etiology of a number of physiological and pathological conditions, and diseases. Oxidative stress, produced by excess ROS, has been identified to serve a critical role in the injury and degeneration of RPE. In the present study, it was observed that the level of intercellular ROS were increased significantly after H2O2 treatment, as demonstrated by the conversion of DCFH-DA into DCF, while pretreatment with quercetin significantly reduced ROS accumulation, indicating that the cytoprotection conferred by quercetin was due to its antioxidant effect.

It is well-known that Nrf2 is a ubiquitous transcription factor, which significantly influences the maintenance of cellular redox status. During homeostasis, Nrf2 is sequestered in the cytoplasm by binding to cytoskeleton-binding Kelch-like ECH-associated protein 1 (Keap1) and degraded through the ubiquitin-26S proteasome pathway. Under oxidative stress, Nrf2 is uncoupled with Keap1 and is rapidly translocated into the nucleus, were it heterodimerizes with Maf proteins and binds to the antioxidant response elements (AREs) in the promoters of its target genes, such as NQO1 and HO-1 (15). A previous study demonstrated that quercetin could activate Nrf2 by upregulating the steady-state level of Nrf2 at the transcriptional level, as well as stabilizing Nrf2 protein post-transcription in HepG2 cells (16). In keeping with these findings, the present study provided direct evidence that quercetin alone had the potential of elevating the expression levels of Nrf2 and NQO1 in a time-dependent manner. It was confirmed that quercetin treatment significantly resulted in translocation of Nrf2 to the nucleus, as detected by immunostaining. In addition, the expression levels of Nrf2 and its target genes were significantly elevated in cells following quercetin pretreatment, compared with H2O2 treatment alone. Therefore, quercetin exerts anti-oxidative effects on ARPE-19 cells via the Nrf2-ARE signaling pathway.

There is increasing evidence that induction of ER stress occurs in exposure to oxidative stress, which serves a crucial role in the RPE cell dysfunction and death. Oxidative stress and ER stress are interrelated biological events, and both participate in RPE apoptosis. Previous studies have demonstrated that oxidative stress increases the accumulation of ROS in the ER and subsequently triggers ER stress after H2O2 stimulation or A2E and blue light-induced damage (17,18). Huang et al (19) revealed that cigarette smoke extract (CSE) exposure induced a dose- and time-dependent increase in ER stress markers, and enhanced ROS, mitochondrial fragmentation and apoptosis of RPE cells, while the ROS scavenger N-acetylcysteine reduced the expression of ER stress protein. These findings suggested a close interaction between oxidative and ER stress in CSE-induced apoptosis (19). In the present study, it was observed that H2O2 increased the level of intracellular ROS and triggered ER stress markers expression in ARPE-19 cells. However, quercetin could significantly reduce ROS accumulation, and decrease the expression levels of ER stress markers Bip and CHOP. As ROS have been demonstrated to trigger ER stress, it could be hypothesized that the anti-oxidative activity of quercetin partially contributed to the inhibitory effect on ER stress. In addition, the results demonstrated that CHOP upregulation was in consistent with the increase in phosphorylation of eIF2α, a downstream target of protein kinase RNA-like endoplasmic reticulum kinase (PERK), suggesting activation of the PERK-eIF2α-activator of transcription factor 4 (ATF4)-CHOP branch of ER stress pathways. In response to stressors, PERK phosphorylates eIF2α to repress translation of proteins. eIF2α phosphorylation preferentially upregulates the translation of ATF4, which then activates expression of its downstream target genes (20). Thus, pretreatment with quercetin may re-establish ER homoeostasis. Hayakawa et al (21) demonstrated that quercetin could reduce eIF2α phosphorylation and ATF4 expression via damaged-inducible gene 34 induction in the brain. However, the ROS-independent effects of quercetin on alleviating ER stress require further investigation.

Bcl-2 and Bax, belonging to the Bcl-2 family, are associated with physiological and pathological apoptosis. Bcl-2 mediates cell survival through sequestration of BH3-only proteins, which are necessary for Bax-mediated mitochondrial permeabilization and apoptosis (22). The anti-apoptotic effects of quercetin have been reported in several cells, including neural, cardiomyoblast and endothelial cells (23,24). The results of the present study have demonstrated that quercetin pretreatment reduced the production of Bax and promoted the generation of Bcl-2, thereby indicating that quercetin might protect ARPE-19 cells by activating pro-survival proteins and inhibiting pro-apoptotic proteins. ER stress can regulate a number of apoptosis-associated proteins that localize on the mitochondrial membrane, particularly the members of the Bcl-2 family. CHOP has been defined as a pivotal mediator of cell death signaling in ER stress, and it also has been suggested that prolonged activation of CHOP promotes apoptosis by downregulating the expression of Bcl-2 (25). Quercetin may upregulate Bcl-2 expression partially by suppressing the expression of CHOP. However, according to previous research, quercetin treatment could result in cell apoptosis in different kinds of cancer cells. Quercetin directly binds to the BH3 domain of Bcl-2 and Bcl-xL proteins, thereby inhibiting their activity and promoting cancer cell apoptosis (26). Therefore, quercetin might have contrasting effects under different conditions.

Xu et al (27) demonstrated that quercetin did not effectively reduce the contents of ROS in H2O2-treated ARPE-19 cells, whereas the phospholipid complex (PC) of quercetin could significantly decrease their level. Quercetin-PC, but not quercetin, was demonstrated to upregulate the protein expression levels of HO-1 and NQO1. Contradictory to this, the result of the present study demonstrated that 20 uM quercetin could significantly elevate Nrf2 and NQO1 in a time-dependent manner, ROS accumulation was reduced following pretreatment with quercetin. Consistent with this, Zhu et al (28) revealed that quercetin (20 µΜ) significantly blocked UVB irradiation (15 mJ/cm2)-induced intracellular ROS generation (28). Therefore, it was hypothesized that quercetin could have antioxidant properties in H2O2-treated ARPE-19 cells at relatively low concentrations. Kook et al (29) first demonstrated that quercetin was able to protect RPE cells from oxidative damage and cellular senescence in vitro in a dose-dependent manner.

In conclusion, the present study confirmed the antioxidant effect of quercetin in ARPE-19 cells and further highlighted the possible mechanisms-activation of the Nrf2 signaling pathway, attenuation of ER stress, and the involvement in regulation of apoptosis. These findings offer some novel therapeutic strategies and methods for various oxidative stress-associated retinal degenerative diseases, such as AMD.

Acknowledgements

The present study was supported by the National Natural Science Foundation of China (grant nos. 81300774 and 81200701) and the Natural Science Foundation of Shanghai (grant no. 12ZR1424500).

References

1 

Friedman DS, O'Colmain BJ, Muñoz B, Tomany SC, McCarty C, de Jong PT, Nemesure B, Mitchell P, Kempen J, et al: Eye Diseases Prevalence Research Group: Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 122:564–572. 2004. View Article : Google Scholar : PubMed/NCBI

2 

van Lookeren Campagne M, LeCouter J, Yaspan BL and Ye W: Mechanisms of age-related macular degeneration and therapeutic opportunities. J Pathol. 232:151–164. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Blasiak J, Petrovski G, Vereb Z, Facskó A and Kaarniranta K: Oxidative stress, hypoxia and autophagy in the neovascular processes of age-related macular degeneration. Biomed Res Int. 2014:7680262014. View Article : Google Scholar : PubMed/NCBI

4 

Plafker SM, O'Mealey GB and Szweda LI: Mechanisms for countering oxidative stress and damage in retinal pigment epithelium. Int Rev Cell Mol Biol. 298:135–177. 2012. View Article : Google Scholar : PubMed/NCBI

5 

Zhang Q, Pi J, Woods CG and Andersen ME: A systems biology perspective on Nrf2-mediated antioxidant response. Toxicol Appl Pharmacol. 244:84–97. 2010. View Article : Google Scholar : PubMed/NCBI

6 

Gao X and Talalay P: Induction of phase 2 genes by sulforaphane protects retinal pigment epithelial cells against photooxidative damage. Proc Natl Acad Sci USA. 101:10446–10451. 2004. View Article : Google Scholar : PubMed/NCBI

7 

Li Z, Dong X, Liu H, Chen X, Shi H, Fan Y, Hou D and Zhang X: Astaxanthin protects ARPE-19 cells from oxidative stress via upregulation of Nrf2-regulated phase II enzymes through activation of PI3K/Akt. Mol Vis. 19:1656–1666. 2013.PubMed/NCBI

8 

Sachdeva MM, Cano M and Handa JT: Nrf2 signaling is impaired in the aging RPE given an oxidative insult. Exp Eye Res. 119:111–114. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Dandekar A, Mendez R and Zhang K: Cross talk between ER stress, oxidative stress, and inflammation in health and disease. Methods Mol Biol. 1292:205–214. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Libby RT and Gould DB: Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration. Adv Exp Med Biol. 664:403–409. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Zhao Z, Sun T, Jiang Y, Wu L, Cai X and Sun X and Sun X: Photooxidative damage in retinal pigment epithelial cells via GRP78 and the protective role of grape skin polyphenols. Food Chem Toxicol. 74:216–224. 2014. View Article : Google Scholar : PubMed/NCBI

12 

D'Andrea G: Quercetin: A flavonol with multifaceted therapeutic applications? Fitoterapia. 106:256–271. 2015. View Article : Google Scholar : PubMed/NCBI

13 

Kobylinska A and Janas KM: Health-promoting effect of quercetin in human diet. Postepy Hig Med Dosw (Online). 69:51–62. 2015.(In Polish). View Article : Google Scholar : PubMed/NCBI

14 

Kook D, Wolf AH, Yu AL, Neubauer AS, Priglinger SG, Kampik A and Welge-Lüssen UC: The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci. 49:1712–1720. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Kaspar JW, Niture SK and Jaiswal AK: Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free Radic Biol Med. 47:1304–1309. 2009. View Article : Google Scholar : PubMed/NCBI

16 

Tanigawa S, Fujii M and Hou DX: Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic Biol Med. 42:1690–1703. 2007. View Article : Google Scholar : PubMed/NCBI

17 

He S, Yaung J, Kim YH, Barron E, Ryan SJ and Hinton DR: Endoplasmic reticulum stress induced by oxidative stress in retinal pigment epithelial cells. Graefes Arch Clin Exp Ophthalmol. 246:677–683. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Feng J, Chen X and Sun X, Wang F and Sun X: Expression of endoplasmic reticulum stress markers GRP78 and CHOP induced by oxidative stress in blue light-mediated damage of A2E-containing retinal pigment epithelium cells. Ophthalmic Res. 52:224–233. 2014. View Article : Google Scholar : PubMed/NCBI

19 

Huang C, Wang JJ, Ma JH, Jin C, Yu Q and Zhang SX: Activation of the UPR protects against cigarette smoke-induced RPE apoptosis through up-regulation of Nrf2. J Biol Chem. 290:5367–5380. 2015. View Article : Google Scholar : PubMed/NCBI

20 

Jiang ZQ, Ma YX, Li MH, Zhan XQ, Zhang X and Wang MY: 5-Hydroxymethylfurfural protects against ER stress-induced apoptosis in GalN/TNF-α-injured L02 hepatocytes through regulating the PERK-eIF2α signaling pathway. Chin J Nat Med. 13:896–905. 2015.PubMed/NCBI

21 

Hayakawa M, Itoh M, Ohta K, Li S, Ueda M, Wang MX, Nishida E, Islam S, Suzuki C, Ohzawa K, et al: Quercetin reduces eIF2α phosphorylation by GADD34 induction. Neurobiol Aging. 36:2509–2518. 2015. View Article : Google Scholar : PubMed/NCBI

22 

Zheng JH, Follis A Viacava, Kriwacki RW and Moldoveanu T: Discoveries and controversies in BCL-2 protein-mediated apoptosis. FEBS J. 283:2690–7000. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Suematsu N, Hosoda M and Fujimori K: Protective effects of quercetin against hydrogen peroxide-induced apoptosis in human neuronal SH-SY5Y cells. Neurosci Lett. 504:223–227. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Wang XQ, Yao RQ, Liu X, Huang JJ, Qi DS and Yang LH: Quercetin protects oligodendrocyte precursor cells from oxygen/glucose deprivation injury in vitro via the activation of the PI3K/Akt signaling pathway. Brain Res Bull. 86:277–284. 2011. View Article : Google Scholar : PubMed/NCBI

25 

Liu K, Shi Y, Guo X, Wang S, Ouyang Y, Hao M, Liu D, Qiao L, Li N, Zheng J and Chen D: CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2. Cell Death Dis. 5:e13232014. View Article : Google Scholar : PubMed/NCBI

26 

Primikyri A, Chatziathanasiadou MV, Karali E, Kostaras E, Mantzaris MD, Hatzimichael E, Shin JS, Chi SW, Briasoulis E, Kolettas E, et al: Direct binding of Bcl-2 family proteins by quercetin triggers its pro-apoptotic activity. ACS Chem Biol. 9:2737–2741. 2014. View Article : Google Scholar : PubMed/NCBI

27 

Xu XR, Yu HT, Yang Y, Hang L, Yang XW and Ding SH: Quercetin phospholipid complex significantly protects against oxidative injury in ARPE-19 cells associated with activation of Nrf2 pathway. Eur J Pharmacol. 770:1–8. 2016. View Article : Google Scholar : PubMed/NCBI

28 

Zhu X, Li N, Wang Y, Ding L, Chen H, Yu Y and Shi X: Protective effects of quercetin on UVB irradiation-induced cytotoxicity through ROS clearance in keratinocyte cells. Oncol Rep. 37:209–218. 2017.PubMed/NCBI

29 

Kook D, Wolf AH, Yu AL, Neubauer AS, Priglinger SG, Kampik A and Welge-Lüssen UC: The protective effect of quercetin against oxidative stress in the human RPE in vitro. Invest Ophthalmol Vis Sci. 49:1712–1720. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Weng S, Mao L, Gong Y, Sun T and Gu Q: Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition. Mol Med Rep 16: 3461-3468, 2017.
APA
Weng, S., Mao, L., Gong, Y., Sun, T., & Gu, Q. (2017). Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition. Molecular Medicine Reports, 16, 3461-3468. https://doi.org/10.3892/mmr.2017.6964
MLA
Weng, S., Mao, L., Gong, Y., Sun, T., Gu, Q."Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition". Molecular Medicine Reports 16.3 (2017): 3461-3468.
Chicago
Weng, S., Mao, L., Gong, Y., Sun, T., Gu, Q."Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition". Molecular Medicine Reports 16, no. 3 (2017): 3461-3468. https://doi.org/10.3892/mmr.2017.6964
Copy and paste a formatted citation
x
Spandidos Publications style
Weng S, Mao L, Gong Y, Sun T and Gu Q: Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition. Mol Med Rep 16: 3461-3468, 2017.
APA
Weng, S., Mao, L., Gong, Y., Sun, T., & Gu, Q. (2017). Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition. Molecular Medicine Reports, 16, 3461-3468. https://doi.org/10.3892/mmr.2017.6964
MLA
Weng, S., Mao, L., Gong, Y., Sun, T., Gu, Q."Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition". Molecular Medicine Reports 16.3 (2017): 3461-3468.
Chicago
Weng, S., Mao, L., Gong, Y., Sun, T., Gu, Q."Role of quercetin in protecting ARPE‑19 cells against H2O2‑induced injury via nuclear factor erythroid 2 like 2 pathway activation and endoplasmic reticulum stress inhibition". Molecular Medicine Reports 16, no. 3 (2017): 3461-3468. https://doi.org/10.3892/mmr.2017.6964
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team